FBN1 and osteosarcoma: Silencing lncRNA-PGM5-AS1 increases miR-140-5p expression, which in turn reduces FBN1 levels, thereby attenuating in vitro osteosarcoma epithelial-mesenchymal transition (EMT), invasion and migration, and in vivo tumorigenesis (Liu et al., 2020).